Your browser is no longer supported. Please, upgrade your browser.
TLRY [NASD]
Tilray, Inc.
Index- P/E- EPS (ttm)-1.17 Insider Own1.90% Shs Outstand460.25M Perf Week-15.72%
Market Cap2.76B Forward P/E- EPS next Y-0.24 Insider Trans-6.33% Shs Float441.95M Perf Month-26.24%
Income- PEG- EPS next Q-0.09 Inst Own13.30% Short Float11.24% Perf Quarter-49.91%
Sales563.62M P/S4.90 EPS this Y36.60% Inst Trans0.54% Short Ratio2.06 Perf Half Y-57.40%
Book/sh9.64 P/B0.60 EPS next Y- ROA- Target Price9.35 Perf Year-67.87%
Cash/sh0.70 P/C8.32 EPS next 5Y- ROE- 52W Range5.90 - 67.00 Perf YTD-17.64%
Dividend- P/FCF- EPS past 5Y- ROI-5.50% 52W High-91.36% Beta2.39
Dividend %- Quick Ratio1.50 Sales past 5Y109.70% Gross Margin- 52W Low-1.86% ATR0.54
Employees2100 Current Ratio2.20 Sales Q/Q174.20% Oper. Margin- RSI (14)29.33 Volatility7.01% 7.46%
OptionableYes Debt/Eq0.17 EPS Q/Q97.90% Profit Margin- Rel Volume1.01 Prev Close5.92
ShortableYes LT Debt/Eq0.16 EarningsJan 10 BMO Payout- Avg Volume24.12M Price5.79
Recom3.00 SMA20-17.02% SMA50-34.27% SMA200-55.96% Volume24,332,119 Change-2.20%
Nov-18-21Initiated Barclays Underweight $10
Nov-01-21Downgrade Cantor Fitzgerald Overweight → Neutral $18 → $11.80
Jun-11-21Downgrade CIBC Sector Outperform → Neutral $25
Jun-03-21Upgrade Cantor Fitzgerald Neutral → Overweight $30.25 → $22
May-11-21Resumed Cowen Outperform $20
May-07-21Resumed Jefferies Buy $23
May-06-21Initiated Canaccord Genuity Hold $17
May-06-21Initiated Canaccord Genuity Buy $17
Apr-28-21Resumed BofA Securities Buy $23
Feb-18-21Downgrade The Benchmark Company Buy → Hold
Feb-18-21Downgrade Piper Sandler Overweight → Neutral $15 → $26
Nov-16-20Downgrade Jefferies Hold → Underperform $5.60 → $4.77
Nov-11-20Downgrade Stifel Hold → Sell $6 → $4.75
Oct-01-20Reiterated MKM Partners Neutral $8 → $6
Sep-21-20Upgrade Jefferies Underperform → Hold $5.60
May-12-20Reiterated The Benchmark Company Buy $28 → $14
Apr-16-20Downgrade Jefferies Hold → Underperform $5
Apr-09-20Downgrade Consumer Edge Research Overweight → Equal Weight
Feb-24-20Downgrade Cowen Outperform → Market Perform $40 → $20
Jan-13-20Initiated BofA/Merrill Neutral $18
Jan-22-22 02:30PM  
Jan-21-22 05:38PM  
02:34PM  
Jan-20-22 02:13PM  
08:00AM  
Jan-19-22 07:08AM  
Jan-18-22 11:05AM  
11:05AM  
Jan-14-22 04:16PM  
10:09AM  
Jan-13-22 01:00PM  
10:48AM  
Jan-12-22 11:29AM  
07:50AM  
05:41AM  
Jan-11-22 02:20PM  
02:18PM  
10:12AM  
07:30AM  
06:27AM  
Jan-10-22 07:05PM  
05:36PM  
04:32PM  
04:20PM  
04:15PM  
03:58PM  
02:35PM  
01:45PM  
12:25PM  
11:33AM  
11:17AM  
11:00AM  
10:37AM  
08:56AM  
07:36AM  
07:27AM  
07:11AM  
07:00AM  
05:20AM  
04:45AM  
03:04AM  
Jan-09-22 08:56AM  
Jan-07-22 05:38PM  
03:38PM  
Jan-06-22 01:01PM  
05:25AM  
Jan-05-22 01:38PM  
11:06AM  
09:05AM  
Jan-04-22 02:51PM  
10:05AM  
06:00AM  
Jan-03-22 10:39AM  
06:00AM  
Dec-31-21 06:00AM  
Dec-30-21 10:22AM  
Dec-24-21 05:45PM  
Dec-23-21 08:50AM  
08:38AM  
Dec-22-21 05:50PM  
Dec-21-21 12:13PM  
Dec-20-21 11:41AM  
07:30AM  
Dec-17-21 05:32PM  
03:59PM  
Dec-16-21 11:38AM  
06:13AM  
Dec-13-21 03:21PM  
07:00AM  
Dec-10-21 12:33PM  
10:28AM  
Dec-09-21 03:53PM  
Dec-08-21 09:06AM  
07:27AM  
07:00AM  
Dec-07-21 01:32PM  
Dec-03-21 03:31PM  
Dec-02-21 08:30AM  
07:30AM  
Nov-30-21 05:31PM  
02:03PM  
08:56AM  
Nov-29-21 01:01PM  
10:41AM  
08:28AM  
Nov-23-21 09:02AM  
Nov-22-21 05:15PM  
03:12PM  
01:11PM  
Nov-21-21 07:55AM  
Nov-20-21 06:25AM  
Nov-19-21 05:23PM  
Nov-18-21 04:59PM  
01:30PM  
01:26PM  
08:54AM  
Nov-17-21 01:08PM  
Nov-16-21 02:34PM  
07:30AM  
Nov-15-21 01:37PM  
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kennedy BrendanDirectorAug 05Sale14.46300,0004,338,5707,974,196Aug 06 08:00 PM
Kennedy BrendanDirectorAug 04Sale14.08300,0004,224,2708,274,196Aug 06 08:00 PM
Kennedy BrendanDirectorJul 16Sale14.04300,0004,211,4308,574,196Jul 19 08:01 PM
Kennedy BrendanDirectorJul 15Sale14.67300,0004,400,8388,874,196Jul 19 08:01 PM
Kennedy BrendanDirectorJun 18Sale17.19400,0006,874,0409,174,196Jun 24 04:16 PM
Kennedy BrendanDirectorJun 17Sale17.97400,0007,186,6409,574,196Jun 24 04:16 PM
Merton Carl AChief Financial OfficerMay 14Option Exercise11.5641,500479,740210,605May 18 07:11 PM
Merton Carl AChief Financial OfficerMay 12Sale14.8289,0001,318,980169,105May 14 08:26 PM